[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Natera Inc (NTRA)

Natera Inc (NTRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 38,719,604
  • Shares Outstanding, K 143,215
  • Annual Sales, $ 2,306 M
  • Annual Income, $ -208,160 K
  • EBIT $ -317 M
  • EBITDA $ -273 M
  • 60-Month Beta 1.51
  • Price/Sales 16.63
  • Price/Cash Flow N/A
  • Price/Book 21.48

Options Overview Details

View History
  • Implied Volatility 62.26% (+0.10%)
  • Historical Volatility 44.03%
  • IV Percentile 84%
  • IV Rank 66.12%
  • IV High 76.67% on 04/23/26
  • IV Low 34.14% on 08/19/25
  • Expected Move (DTE 16) 0.00 (0.00%)
  • Put/Call Vol Ratio 1.62
  • Today's Volume 3,857
  • Volume Avg (30-Day) 1,093
  • Put/Call OI Ratio 0.85
  • Today's Open Interest 28,851
  • Open Int (30-Day) 30,189
  • Expected Range 275.19 to 275.19

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 23 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.44
  • Number of Estimates 3
  • High Estimate $-0.36
  • Low Estimate $-0.59
  • Prior Year $-0.74
  • Growth Rate Est. (year over year) +40.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
248.03 +10.95%
on 07/29/26
288.04 -4.46%
on 07/06/26
-4.13 (-1.48%)
since 07/02/26
3-Month
184.81 +48.90%
on 05/15/26
288.04 -4.46%
on 07/06/26
+63.63 (+30.08%)
since 05/04/26
52-Week
134.85 +104.07%
on 08/05/25
288.04 -4.46%
on 07/06/26
+138.62 (+101.50%)
since 08/04/25

Most Recent Stories

More News
Natera (NTRA) Reports Q2: Everything You Need To Know Ahead Of Earnings

Natera (NTRA) Reports Q2: Everything You Need To Know Ahead Of Earnings

NTRA : 275.19 (+1.79%)
Natera to Report its Second Quarter Results on August 6, 2026

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will release results for its second quarter ended June 30, 2026, after the market closes...

NTRA : 275.19 (+1.79%)
1 Unpopular Stock That Deserves Some Love and 2 We Question

1 Unpopular Stock That Deserves Some Love and 2 We Question

NTRA : 275.19 (+1.79%)
BBY : 86.35 (+1.29%)
AMCX : 11.40 (+4.59%)
3 Reasons We’re Fans of Natera (NTRA)

3 Reasons We’re Fans of Natera (NTRA)

NTRA : 275.19 (+1.79%)
Signatera™ MRD Outperformed AMERK Testing in Predicting Merkel Cell Carcinoma Recurrence in JAMA Dermatology Study

Signatera outperformed AMERK, the current standard of care for prognosis and recurrence monitoring, across sensitivity, positive and negative predictive value, and lead time to recurrence

NTRA : 275.19 (+1.79%)
3 Market-Beating Stocks Worth Your Attention

3 Market-Beating Stocks Worth Your Attention

NTRA : 275.19 (+1.79%)
SRCE : 90.82 (+0.34%)
IRTC : 127.13 (+1.98%)
Finalized MolDx LCD Includes Expanded Coverage for Natera’s Prospera™ Portfolio

Surveillance coverage significantly strengthened with new LCD across kidney, heart, and lung transplantation, expanding coverage for Prospera testing across critical post-transplant settings

NTRA : 275.19 (+1.79%)
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks

Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks

NTRA : 275.19 (+1.79%)
1 Cash-Producing Stock with Exciting Potential and 2 We Brush Off

1 Cash-Producing Stock with Exciting Potential and 2 We Brush Off

NTRA : 275.19 (+1.79%)
IEX : 237.89 (+2.23%)
DPZ : 367.63 (+0.88%)
Natera Announces IVDR Certification for Signatera™ Across Multiple Cancers

Signatera is the first personalized molecular residual disease (MRD) test for solid tumors to receive IVDR certification in the EU

NTRA : 275.19 (+1.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.

See More

Key Turning Points

3rd Resistance Point 291.42
2nd Resistance Point 284.20
1st Resistance Point 279.69
Last Price 275.19
1st Support Level 267.96
2nd Support Level 260.74
3rd Support Level 256.23

See More

52-Week High 288.04
Last Price 275.19
Fibonacci 61.8% 229.52
Fibonacci 50% 211.45
Fibonacci 38.2% 193.37
52-Week Low 134.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.